#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Antibiotic Treatment in Patients with Febrile Neutropenia


Authors: M. Kolář;  E. Faber;  J. Lochmannová jr.;  T. Papajík;  J. Hubáček;  L. Raida
Authors‘ workplace: Ústav mikrobiologie LF UP a FN, Olomouc Hemato- onkologická klinika LF UP a FN, Olomouc Interní klinika 2. LF UK, Praha
Published in: Transfuze Hematol. dnes,, 2002, No. 1, p. 20-24.
Category:

Overview

Patients with febrile neutropenie and depressed function of immune system represent a special group. As an etiological agent may play a role the bacteria which cause infection in the subjects with normal immune functions less frequently. The adequate antimicrobial treatment has significantly contributed to the improved prognosis of these patients during the lest 20 years. Aminopenicillins with inhibitors of bacterial beta-lactamase in combination with aminoglycosides or piperacillin/tazobactam may be recommended as a front-line treatment in patients with febrile neutropenie. However, the essential prerequisite is the preserved sensitivity of the most importem gram-negative bacterial pathogens to these antimicrobial preparations. The above-mentioned regimens may have a positive impact on the prevention of occurrence of vancomycin-resistant enterococci that represent a serious threat for haemato-oncological patients.

Key words:
febrile neutropenie, antibiotic treatment, vancomycin-resistant enterococci

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Haematology Internal medicine Clinical oncology
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#